CP-226,269
![]() | |
| Identifiers | |
|---|---|
| |
| CAS Number |
220941-93-5 |
| PubChem (CID) | 9796720 |
| IUPHAR/BPS | 973 |
| ChemSpider |
7972486 |
| ChEMBL |
CHEMBL77395 |
| Chemical and physical data | |
| Formula | C18H19FN4 |
| Molar mass | 310.368 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
CP-226,269 is a drug which acts as a dopamine agonist selective for the D4 subtype, which is used for researching the role of D4 receptors in the brain.[1][2]
References
- ↑ Sharma A, Kramer ML, Wick PF, Liu D, Chari S, Shim S, Tan W, Ouellette D, Nagata M, DuRand CJ, Kotb M, Deth RC (May 1999). "D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia". Molecular Psychiatry. 4 (3): 235–46. doi:10.1038/sj.mp.4000522. PMID 10395213.
- ↑ Basso AM, Gallagher KB, Bratcher NA, Brioni JD, Moreland RB, Hsieh GC, Drescher K, Fox GB, Decker MW, Rueter LE (July 2005). "Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test". Neuropsychopharmacology. 30 (7): 1257–68. doi:10.1038/sj.npp.1300677. PMID 15688083.
This article is issued from Wikipedia - version of the 5/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
